3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Liver Cirrhosis
1
Kidney Neoplasms
1
Glioma
1
Carcinoma, Hepatocellular
1
Interventions
lenvatinib
16
Bevacizumab
14
sintilimab
10
tislelizumab
9
apatinib
9
regorafenib
6
camrelizumab
6
donafenib
5
atezolizumab
5
Immune Checkpoint Inhibitors
4
Hepatectomy
4
cabozantinib
3
Radiosurgery
3
Capecitabine
3
spartalizumab
2
pembrolizumab
2
durvalumab
2
anlotinib
2
Surgical Procedures, Operative
2
Specimen Handling
2
Oxaliplatin
2
Observation
2
Magnetic Resonance Spectroscopy
2
Injections
2
Immunotherapy
2
Folfox protocol
2
Fecal Microbiota Transplantation
2
Electroporation
2
Blood Specimen Collection
2
ursodoxicoltaurine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Carcinoma, Hepatocellular
×
Urination
×
Clear all
NCT07119957
2025-08-13
ProspEXPO
University Hospital, Angers
Phase NA
Not yet recruiting
300 enrolled